Found: 500
Select item for more details and to access through your institution.
SARS-CoV-2 viral load is linked to remdesivir efficacy in severe Covid-19 admitted to intensive care.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-71588-9
- By:
- Publication type:
- Article
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis.
- Published in:
- Wiener Klinische Wochenschrift, 2022, v. 134, n. 23/24, p. 883, doi. 10.1007/s00508-022-02098-9
- By:
- Publication type:
- Article
Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex.
- Published in:
- Cell Biochemistry & Biophysics, 2021, v. 79, n. 2, p. 175, doi. 10.1007/s12013-021-00977-y
- By:
- Publication type:
- Article
Safety and sagacious use of remdesivir: Paramount focus on contemporary perspectives.
- Published in:
- Biomedical & Biotechnology Research Journal, 2022, v. 6, n. 1, p. 1, doi. 10.4103/bbrj.bbrj_161_21
- By:
- Publication type:
- Article
Remdesivir experience in patients diagnosed with COVID-19 in a tertiary hospital.
- Published in:
- Pamukkale Medical Journal, 2023, v. 16, n. 1, p. 1, doi. 10.31362/patd.1102822
- By:
- Publication type:
- Article
Is There Enough Evidence to Avoid Remdesivir Use in Patients with Severe Renal Impairment? A Review of the Pharmacological and Clinical Literature.
- Published in:
- Mediterranean Journal of Infection, Microbes & Antimicrobials, 2021, v. 10, p. 60, doi. 10.4274/mjima.galenos.2021.2021.14
- By:
- Publication type:
- Article
COVID-19 in Children.
- Published in:
- Croatian Journal of Infection / Infektoloski Glasnik, 2021, v. 41, n. 1, p. 15, doi. 10.37797/ig.41.1.3
- By:
- Publication type:
- Article
IN SILICO BASED SCREENING EMPLOYED TO ASSESS THE ACTIVITY OF PHYTOCHEMICAL, SYNTHETIC AND MARINE COMPOUNDS ON THE SARS-COV-2 MAIN PROTEASE.
- Published in:
- Indian Drugs, 2024, v. 61, n. 7, p. 23, doi. 10.53879/id.61.07.14596
- By:
- Publication type:
- Article
Remdesivir in Severe COVID-19 and Non-Invasive Ventilation: A Real-Life Experience.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 9, p. 1108, doi. 10.3390/healthcare9091108
- By:
- Publication type:
- Article
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae202
- By:
- Publication type:
- Article
P5‐47: Safety and efficacy of remdesivir, baricitinib and high‐dose steroid combination therapy in patients hospitalized with COVID‐19.
- Published in:
- Respirology, 2021, v. 26, p. 175, doi. 10.1111/resp.14150_254
- Publication type:
- Article
O8‐3: The effectiveness of the combined use of remdesivir and regdanvimab (CT‐P59) in patients with severe COVID‐19: A single center retrospective study.
- Published in:
- Respirology, 2021, v. 26, p. 23, doi. 10.1111/resp.14149_46
- Publication type:
- Article
P5‐47: Safety and efficacy of remdesivir, baricitinib and high‐dose steroid combination therapy in patients hospitalized with COVID‐19.
- Published in:
- Respirology, 2021, v. 26, p. 175, doi. 10.1111/resp.14150_254
- Publication type:
- Article
O8‐3: The effectiveness of the combined use of remdesivir and regdanvimab (CT‐P59) in patients with severe COVID‐19: A single center retrospective study.
- Published in:
- Respirology, 2021, v. 26, p. 23, doi. 10.1111/resp.14149_46
- Publication type:
- Article
Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 5, p. 1052, doi. 10.3390/cells10051052
- By:
- Publication type:
- Article
Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS).
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1349543
- By:
- Publication type:
- Article
Case report: Clearance of longstanding, immunedeficiency-associated, vaccinederived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1135834
- By:
- Publication type:
- Article
Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1015355
- By:
- Publication type:
- Article
Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.830990
- By:
- Publication type:
- Article
Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection – a single-center, retrospective, cohort study.
- Published in:
- European Journal of Pediatrics, 2024, v. 183, n. 2, p. 591, doi. 10.1007/s00431-023-05287-4
- By:
- Publication type:
- Article
A CONCISE REVIEW ON ANALYTICAL METHOD DEVELOPED FOR THE ESTIMATION OF REMDESIVIR.
- Published in:
- Pharma Science Monitor, 2023, v. 14, n. 2, p. 1
- By:
- Publication type:
- Article
A systematic review and meta-analysis of randomized controlled trials with trial sequence analysis of remdesivir for COVID-19 treatment.
- Published in:
- International Journal of Critical Illness & Injury Science, 2023, v. 13, n. 4, p. 184, doi. 10.4103/ijciis.ijciis_23_23
- By:
- Publication type:
- Article
An Unnecessary Gift for COVID-19 Vaccines and Therapeutics: The Medical Countermeasure Priority Review Voucher.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic.
- Published in:
- Drug Discoveries & Therapeutics, 2020, v. 14, n. 6, p. 273, doi. 10.5582/ddt.2020.03097
- By:
- Publication type:
- Article
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
- Published in:
- Drug Discoveries & Therapeutics, 2020, v. 14, n. 1, p. 58, doi. 10.5582/ddt.2020.01012
- By:
- Publication type:
- Article
NIH funds study to evaluate remdesivir for COVID-19 in pregnancy.
- Published in:
- Neonatology Today, 2021, v. 16, n. 2, p. 98
- By:
- Publication type:
- Article
Effects of Remdesivir on in-Hospital and Late Outcomes of Patients With Confirmed or Clinically Suspected COVID-19: A Propensity Score-Matched Study.
- Published in:
- Acta Medica Iranica, 2022, v. 60, n. 7, p. 407
- By:
- Publication type:
- Article
Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study.
- Published in:
- Journal of Infection in Developing Countries, 2023, v. 17, n. 7, p. 953, doi. 10.3855/jidc.17971
- By:
- Publication type:
- Article
Outcome of COVID-19 and tolerance of Remdesivir in patients with renal failure: a single center experience from Pakistan.
- Published in:
- Journal of Infection in Developing Countries, 2023, v. 17, n. 6, p. 812, doi. 10.3855/jidc.17136
- By:
- Publication type:
- Article
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.
- Published in:
- Intensive Care Medicine, 2021, v. 47, n. 11, p. 1258, doi. 10.1007/s00134-021-06507-x
- By:
- Publication type:
- Article
Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?
- Published in:
- QJM: An International Journal of Medicine, 2021, v. 114, n. 12, p. 865, doi. 10.1093/qjmed/hcab297
- By:
- Publication type:
- Article
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 10, p. 1318, doi. 10.1093/infdis/jiad275
- By:
- Publication type:
- Article
Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1).
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 9, p. 1263, doi. 10.1093/infdis/jiad270
- By:
- Publication type:
- Article
Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2020, v. 63, n. 3, p. 396, doi. 10.1165/rcmb.2020-0206LE
- By:
- Publication type:
- Article
Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09708-z
- By:
- Publication type:
- Article
Clinical evolution and mortality of critically ill patients with SARS-CoV-2 pneumonia treated with remdesivir in an adult intensive care unit of Paraguay.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-023-08917-2
- By:
- Publication type:
- Article
Propensity score matched analysis for the safety and effectiveness of remdesivir in COVID-19 patients with renal impairment.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-023-08859-9
- By:
- Publication type:
- Article
GPU-Enhanced DFTB Metadynamics for Efficiently Predicting Free Energies of Biochemical Systems.
- Published in:
- Molecules, 2023, v. 28, n. 3, p. 1277, doi. 10.3390/molecules28031277
- By:
- Publication type:
- Article
Clarifying the Use of Benzylidene Protecting Group for D-(+)-Ribono-1,4-Lactone, an Essential Building Block in the Synthesis of C -Nucleosides.
- Published in:
- Molecules, 2021, v. 26, n. 21, p. 6447, doi. 10.3390/molecules26216447
- By:
- Publication type:
- Article
Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E).
- Published in:
- Molecules, 2020, v. 25, n. 10, p. 2343, doi. 10.3390/molecules25102343
- By:
- Publication type:
- Article
COVID-19 and Chronic Kidney Disease: A Narrative Review.
- Published in:
- COVID, 2023, v. 3, n. 8, p. 1092, doi. 10.3390/covid3080080
- By:
- Publication type:
- Article
Real-World Safety and Effectiveness of Remdesivir and Corticosteroids in Hospitalized Patients with COVID-19.
- Published in:
- COVID, 2023, v. 3, n. 2, p. 198, doi. 10.3390/covid3020015
- By:
- Publication type:
- Article
Clinical Outcomes and Survival Analysis of Remdesivir as a Treatment Option for Moderate to Severe COVID-19 Patients.
- Published in:
- COVID, 2022, v. 2, n. 12, p. 1758, doi. 10.3390/covid2120126
- By:
- Publication type:
- Article
EFFECTS OF ANTIVIRAL THERAPEUTIC DRUGS FOR SARS-COV-2 ON TREATMENT OUTCOMES AND CLINICAL PARAMETERS.
- Published in:
- Eurasian Journal of Ecology, 2024, v. 79, n. 2, p. 136, doi. 10.26577/EJE.2024.v79.i2-013
- By:
- Publication type:
- Article
Evidence, end-points, and epistemic - Handling the uncertainty of COVID-19-related infodemic.
- Published in:
- Journal of Current Research in Scientific Medicine, 2021, v. 7, n. 1, p. 51, doi. 10.4103/jcrsm.jcrsm_61_20
- By:
- Publication type:
- Article
Mucocutaneous Adverse Effects of Remdesivir and Favipiravir in Patients with Covid-19 Infection: A Systematic Review.
- Published in:
- Indian Journal of Dermatopathology & Diagnostic Dermatology, 2022, v. 9, n. 2, p. 47, doi. 10.4103/ijdpdd.ijdpdd_70_21
- By:
- Publication type:
- Article
Co-Administration of Remdesivir and Azithromycin May Protect against Intensive Care Unit Admission in COVID-19 Pneumonia Requiring Hospitalization: A Real-Life Observational Study.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 7, p. 941, doi. 10.3390/antibiotics11070941
- By:
- Publication type:
- Article
Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 2, p. 156, doi. 10.3390/antibiotics11020156
- By:
- Publication type:
- Article
Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 12, p. 1477, doi. 10.3390/antibiotics10121477
- By:
- Publication type:
- Article